US pharmacy operator CVS Health has made an offer to acquire No. 3 US health insurer Aetna for more than US$200 per share, or over US$66 billion, people familiar with the matter said on Thursday, October 26.
A deal would merge one of the nation’s largest pharmacy benefits managers and pharmacy operators with one of its oldest health insurers, whose far-reaching business ranges from employer healthcare to government plans nationwide.
Healthcare consolidation has been a popular route for insurers and pharmacies, under pressure from the government and large corporations to lower soaring medical costs.
A tie-up with Aetna could give CVS more leverage in its price negotiations with drug makers. But it would also subject it to more antitrust scrutiny, according to the WSJ.
The deal could also help counter pressure on CVS’s stock following speculation that Amazon.com is preparing to enter the drug prescription market, using its vast e-commerce platform to take market share from traditional pharmacies.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Dollar Tree to Sell Family Dollar for $1 Billion, Ending Struggling Merger
Mar 26, 2025 by
CPI
Meta Platforms Defends Use of Authors’ Works in AI Training in US Court
Mar 26, 2025 by
CPI
EU Pressed Meta to Address Antitrust Concerns Over Facebook Marketplace
Mar 26, 2025 by
CPI
UBS, Nomura, and UniCredit Fail to Overturn EU Antitrust Fines in Bond Trading Cartel Case
Mar 26, 2025 by
CPI
Coca-Cola Among Firms Targeted in EU Antitrust Raids
Mar 26, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mobile Ecosystems
Mar 24, 2025 by
CPI
Mobile Ecosystems: An Intellectual Entelechy but A Necessary Model
Mar 24, 2025 by
Alba Ribera Martinez
Creating Contestability and Fairness in Mobile Ecosystems: The Contribution of the DMA
Mar 24, 2025 by
Damien Geradin & Daniel Mandrescu
Digital Ecosystems and the Not (Yet) As Efficient Competitor Principle
Mar 24, 2025 by
Thomas Hoppner & Philipp Westerhoff
Assessing the Competition Law Scrutiny of Smart Wearables and Mobile AR/VR Devices
Mar 24, 2025 by
Kayvan Hazemi-Jebelli